Scientific Letter N°19

For this 19th scientific letter of Atlanchim Pharma, we wanted to highlight the chemists who work every day to realize your projects. You will find on the last page the presentation of our project manager, Thibaut MARTINEZ who worked during his thesis on the “Cyclisation of 2-pyridylallenes: towards new indolizine derivatives and chiral carbenic ligands” (Louis Fensterbank, Sorbonne University, IPCM, Paris, 2019)

We are happy to present them to you and thanks to this team of scientists we are enriching the know-how of our beautiful Contract Research Organization.

At Atlanchim Pharma our objective is to be reactive in the return of your requests, to offer you a regular and quality project and customer follow-up, a reinforced scientific communication to better serve you. It is also and above all more than 18 years of experience recognized by our strong expertise in small molecules synthesis, on a laboratory scale, and in the following fields such as : Custom synthesis, from research to reproduction of your documents; site-specific stable isotope labeling; and impurity synthesis: from identification to isolation.

Atlanchim Pharma’s team is pleased to announce that in 2023 we are also bringing change in the communication with a new format of our WEBINARS in English still presented by our Scientific Director, Jacques Lebreton. But also a new website where you will find all our expertise, our scientific publications and much more…

Stay tuned and feel free to subscribe to our newsletters on our website so that you don’t miss the theme of our next Webinar on June, 13th: A VERSATILE REDUCING AGENT .

Enjoy the reading !

Aurélie et Héléna